Green tea and diabetes -
Polyphenols come from plants and help protect our cells from damage. Green tea has a few different types that make up around 40 percent of its dry weight. In addition, green tea may have a calming effect on the mind and body.
It contains the amino acid L-theanine, which Smithson says has a calming effect. According to a study published in October in the Journal of Physiological Anthropology , L-theanine may help reduce anxiety and prevent stress-related increases in blood pressure.
When treating people with diabetes, Hoffman recommends never adding sugar to drinks; instead, she advises drinking unsweetened tea or tea with sugar alternatives, like stevia. Stevia is a sugar substitute that comes from the leaves of the stevia plant.
Hoffman likes it as an option for people with diabetes because it has less than 1 calorie and no carbs per packet. A study published in the journal Appetite suggests that of the low-calorie sweeteners commonly used by people with diabetes including aspartame and sucrose , stevia was the only one shown to lower blood sugar and insulin levels after a meal.
RELATED: 5 Sugar Substitutes for Type 2 Diabetes. If you find green tea to be too bitter, forgo using honey or table sugar brown or white and instead opt for a sweetener such as stevia. When drinking green tea, the other thing to keep in mind is caffeine , which can affect blood sugar and blood pressure.
The latter is of particular concern for people with type 2 diabetes, who are 2 to 4 times as likely to die of heart disease compared with people without type 2 diabetes, according to the American Heart Association. A good way to see how you respond to the amount of caffeine in green tea is to check your blood sugar before drinking the tea and then one to two hours afterward, says Smithson.
Smithson also recommends using a home blood pressure cuff to monitor blood pressure. The good news is that green tea has much less caffeine than coffee or black tea.
But if your body is sensitive to caffeine, it could still be a problem. Green tea is made from fresh leaves, which are steamed to prevent fermentation. The tea keeps its green color and antioxidant compounds.
Oolong tea is slightly fermented, and black tea is fully fermented. If you are sensitive to caffeine, herbal teas can be a great substitute. On this note, Arevalo recommends cinnamon tea for people with type 2 diabetes — for both taste and possible health benefits cinnamon is packed with antioxidants.
Health Conditions A-Z. Best Oils for Skin Complementary Approaches Emotional Wellness Fitness and Exercise Healthy Skin Online Therapy Reiki Healing Resilience Sleep Sexual Health Self Care Yoga Poses See All. Atkins Diet DASH Diet Golo Diet Green Tea Healthy Recipes Intermittent Fasting Intuitive Eating Jackfruit Ketogenic Diet Low-Carb Diet Mediterranean Diet MIND Diet Paleo Diet Plant-Based Diet See All.
Consumer's Guides: Understand Your Treatments Albuterol Inhalation Ventolin Amoxicillin Amoxil Azithromycin Zithromax CoQ10 Coenzyme Q Ibuprofen Advil Levothyroxine Synthroid Lexapro Escitalopram Lipitor Atorvastatin Lisinopril Zestril Norvasc Amlodipine Prilosec Omeprazole Vitamin D3 Xanax Alprazolam Zoloft Sertraline Drug Reviews See All.
Three trials did not report the dropout rate or the reasons for the dropouts [ 28 , 40 , 44 ] Table 2. Primary outcome measures included changes in FBG, FBI, and HbA 1c. Meta-analysis of the effects of green tea on fasting blood glucose concentrations. Meta-analysis of the effects of green tea on fasting blood insulin concentrations.
Meta-analysis of the effects of green tea on HbA lc concentrations. Secondary outcome measures included changes in HOMA-IR concentration. Green tea supplementation had no significant effect on HOMA-IR WMD: In the subgroup analysis, green tea consumption significantly lowered FBG concentrations in subjects using green tea capsule or with high catechins dosage, subjects from western countries, subjects in short duration of green tea supplementation, subjects with normal FBG, studies with caffeinated green tea intake, studies with parallel design, and studies with low quality.
However, significant reduction in fasting glucose was not found in other subgroups. In addition, the beneficial effect for green tea supplementation on fasting insulin was observed in subjects with green tea capsule, subjects from western countries, subjects with normal baseline FBG and studies with decaffeinated green tea intake.
However, no effect was found in other subgroups. Significant reductions in HbA 1c concentrations were observed in subjects from Asian countries, studies with caffeine in green tea and studies with low quality, while the obvious effect was not found in other subgroups Table 3.
Meta-regression found no linear relations between WMD in FBG, FBI or HbA 1C and intervention dose Fig. Furthermore, meta-regression found no linear relations between WMD in FBG or FBI and treatment duration, caffeine content, different ethnicity, intervention type and study design.
a Relation between the WMD of FBG and intervention dose in 27 independent randomized controlled comparisons. b Relation between the WMD of FBI and intervention dose in 18 independent randomized controlled comparisons.
c Relation between the WMD of HbA lc and intervention dose in 11 independent randomized controlled comparisons. Each circle represents a study, telescoped by its weight in the analysis. The funnel plots of the studies were symmetrical for fasting glucose, fasting insulin, and HbA 1c Supplementary Figure 1.
A sensitivity analysis was performed to confirm the robustness of our findings. The result was consistent after removing each trial for both fasting glucose and fasting insulin. In the sensitivity analysis of HbA 1c , the exclusion of one trial [ 22 ] Basu resulted in significant reductions of However, there was no significant reduction in HbA 1c after the removal of other trials.
This meta-analysis involving 27 RCTs with subjects evaluated the effect of green tea supplementation on glycemic control. We found that green tea supplementation significantly reduced FBG concentration, while the effect of green tea on other glycemic variables such as FBI, HbA 1c , and HOMA-IR was not significant.
Our results are consistent with some previous meta-analysis [ 49 , 50 ], which also showed that green tea consumption resulted in a significant reduction in FBG. While, another previous meta-analysis [ 8 ] suggested that green tea consumption had favorable effects on decreasing both FBG and HbA 1c concentrations.
In our study, we did not find a significant improvement in HbA 1c concentrations. Observational prospective cohorts and case-control studies have been performed to determine the effect of green tea supplementation on glycemic control, although the results are conflicting. Some RCTs also found beneficial effects on glycemic control, including reducing fasting glucose and fasting insulin [ 38 , 48 ].
In contrast, several RCTs have reported no significant correlations between green tea intake and glycemic control [ 24 , 27 ]. Nonetheless, these results need to be interpreted with caution because the number of patients enrolled in most trials was too limited, at less than patients; in addition, the intervention duration and catechins dosages were varied among studies.
So, more RCTs with larger subjects and longer duration were needed to find out the real relationship between green tea consumption and blood glucose control.
Recent mechanistic studies have examined the effects of green tea consumption on glucose control and provided further evidence for the biological plausibility of these findings. Green tea may affect glucose control through different mechanisms.
First, tea catechins have been reported to reduce carbohydrate absorption from the intestine via inhibition of intestinal sucrose, alpha-amylase, and alpha-glucosidase [ 10 ]. Second, Tea catechins might also inhibit the hepatic gluconeogenesis through regulation of the expression of gluconeogenic genes and protein-tyrosine phosphorylation in the mouse liver [ 52 ].
Third, tea catechins could enhance insulin sensitivity and glucose metabolism there by helping to prevent the development of T2DM [ 53 ]. Furthermore, Tea catechins are also powerful antioxidants that can ameliorate oxidative stress [ 54 ]. In this meta-analysis, subgroup analyses were performed based on predefined variables to identify potential sources of heterogeneity.
Green tea consumption significantly decreased FBG and FBI only in subjects using green tea capsule. In addition, meta-regression also pointed out that green tea capsule was associated with HbA 1C. Nowadays, there was still insufficient evidence on whether green tea capsule was more biologically active compared to green tea beverage in vivo or vitro studies.
In addition, subgroup analyses revealed that green tea with caffeine had a more pronounced effect on FBG and HbA 1C than the decaffeination subgroup. As tea naturally contains caffeine in addition to catechins and other compounds, whether caffeine intake influences the glucose control of tea remains controversial [ 55 , 56 ].
As there were a limited number of subjects in the subgroup analysis, these results may not be generalized. Our study had several strengths. First, we only selected RCTs in this meta-analysis, which ensured a relatively high-quality and provided reliable inference about causality.
Second, both parallel and crossover studies were included in this meta-analysis. Crossover trials are generally considered to have a more-robust design than parallel trials because of reduced intraparticipant variability.
We considered it important to include all these studies because they represented a comprehensive evidence for our analysis. Third, results were less likely to be influenced by publication bias. Furthermore, subgroup analyses were undertaken to detect potential sources of heterogeneity for primary outcomes.
Our study also had several limitations. HbA 1c is an important indicator for glucose control, including greater pre-analytical stability, greater convenience, and less day-to-day perturbations. In addition, it also takes a number of months to detect delayed effects of green tea on insulin resistance.
In addition, we could not ascertain the safety margin in this meta-analysis because no serious side effects were reported in the included trials. However, mild side effects such as mild skin rashes, gastric disturbances, and abdominal bloating were reported in some clinical studies [ 57 ].
Third, the size of these trials, which ranged between 25 and participants, were indeed limited. Therefore, our meta-analysis may have been underpowered to detect a true effect. Forth, the quality of RCTs included in this meta-analysis varied.
Some of the RCTs did not provide detailed randomization process. Of the 27 trials, almost half of the trials were of high risk of bias, which may also affect the reliability of our findings. In conclusion, green tea intake had a favorable effect on fasting blood glucose concentration.
However, green tea intake did not significantly affect fasting blood insulin or HbA 1c. In future, high-quality larger RCTs with long-term follow-up are needed to investigate the effect of green tea supplementation on glycemic control, especially the long-term effects on fasting insulin and HbA 1c.
Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, Knowler WC, Aroda VR, Brodsky I, Ceglia L, Chadha C, Chatterjee R, Desouza C, Dolor R, Foreyt J, Fuss P, Ghazi A, Hsia DS, Johnson KC, Kashyap SR, Kim S, LeBlanc ES, Lewis MR, Liao E, Neff LM, Nelson J, O'Neil P, Park J, Peters A, Phillips LS, Pratley R, Raskin P, Rasouli N, Robbins D, Rosen C, Vickery EM, Staten M, Group DdR.
Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med. Article CAS PubMed PubMed Central Google Scholar.
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF diabetes atlas: global estimates of diabetes prevalence for and projections for Diabetes Res Clin Pract.
Article CAS PubMed Google Scholar. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Diabetes prevention program research G: reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Lotfy M, Adeghate J, Kalasz H, Singh J, Adeghate E.
Chronic complications of diabetes mellitus: a mini review. Curr Diabetes Rev. Hou LQ, Liu YH, Zhang YY. Garlic intake lowers fasting blood glucose: meta-analysis of randomized controlled trials.
Asia Pac J Clin Nutr. CAS PubMed Google Scholar. Balentine DA, Wiseman SA, Bouwens LC. The chemistry of tea flavonoids. Crit Rev Food Sci Nutr. Khan N, Mukhtar H. Tea polyphenols for health promotion. Life Sci. Liu K, Zhou R, Wang B, Chen K, Shi LY, Zhu JD, Mi MT.
Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. Am J Clin Nutr. Jing Y, Han G, Hu Y, Bi Y, Li L, Zhu D. Tea consumption and risk of type 2 diabetes: a meta-analysis of cohort studies. J Gen Intern Med. Article PubMed PubMed Central Google Scholar.
Collins QF, Liu HY, Pi J, Liu Z, Quon MJ, Cao W. J Biol Chem. Wu LY, Juan CC, Hwang LS, Hsu YP, Ho PH, Ho LT. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur J Nutr.
Belcaro G, Ledda A, Hu S, Cesarone MR, Feragalli B, Dugall M. Greenselect phytosome for borderline metabolic syndrome.
Evid Based Complement Alternat Med. PubMed PubMed Central Google Scholar. Igarashi Y, Obara T, Ishikuro M, Matsubara H, Shigihara M, Metoki H, Kikuya M, Sameshima Y, Tachibana H, Maeda-Yamamoto M, Kuriyama S. Randomized controlled trial of the effects of consumption of 'Yabukita' or 'Benifuuki' encapsulated tea-powder on low-density lipoprotein cholesterol level and body weight.
Food Nutr Res. Article PubMed PubMed Central CAS Google Scholar. Josic J, Olsson AT, Wickeberg J, Lindstedt S, Hlebowicz J.
Does green tea affect postprandial glucose, insulin and satiety in healthy subjects: a randomized controlled trial. Nutr J. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB.
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology MOOSE group. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
Anzures-Cabrera J, Sarpatwari A, Higgins JP. Expressing findings from meta-analyses of continuous outcomes in terms of risks. Stat Med. Article PubMed Google Scholar.
Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol. Higgins JP, Thompson SG.
Quantifying heterogeneity in a meta-analysis. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. Egger M, Davey Smith G, Schneider M, Minder C.
Bias in meta-analysis detected by a simple, graphical test. Basu A, Du M, Sanchez K, Leyva MJ, Betts NM, Blevins S, Wu M, Aston CE, Lyons TJ. Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome.
Bogdanski P, Suliburska J, Szulinska M, Stepien M, Pupek-Musialik D, Jablecka A. Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res. Brown AL, Lane J, Coverly J, Stocks J, Jackson S, Stephen A, Bluck L, Coward A, Hendrickx H.
Effects of dietary supplementation with the green tea polyphenol epigallocatechingallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr.
Brown AL, Lane J, Holyoak C, Nicol B, Mayes AE, Dadd T. Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. Chan CC, Koo MW, Ng EH, Tang OS, Yeung WS, Ho PC. Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome--a randomized placebo-controlled trial.
J Soc Gynecol Investig. Chen IJ, Liu CY, Chiu JP, Hsu CH. Therapeutic effect of high-dose green tea extract on weight reduction: a randomized, double-blind, placebo-controlled clinical trial.
Clin Nutr. Diepvens K, Kovacs EM, Vogels N, Westerterp-Plantenga MS. Metabolic effects of green tea and of phases of weight loss. Physiol Behav.
Dostal AM, Samavat H, Espejo L, Arikawa AY, Stendell-Hollis NR, Kurzer MS. Green tea extract and catechol-O-methyltransferase genotype modify fasting serum insulin and plasma Adiponectin concentrations in a randomized controlled trial of overweight and obese postmenopausal women.
J Nutr. Frank J, George TW, Lodge JK, Rodriguez-Mateos AM, Spencer JP, Minihane AM, Rimbach G. Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. Fukino Y, Shimbo M, Aoki N, Okubo T, Iso H.
Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol Tokyo. Article CAS Google Scholar. Fukino Y, Ikeda A, Maruyama K, Aoki N, Okubo T, Iso H.
Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr. Hill AM, Coates AM, Buckley JD, Ross R, Thielecke F, Howe PR.
Can EGCG reduce abdominal fat in obese subjects? J Am Coll Nutr. Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, Chou P. Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial.
Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, Chou P. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics?
A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev. Kovacs EM, Lejeune MP, Nijs I, Westerterp-Plantenga MS. Effects of green tea on weight maintenance after body-weight loss. Liu CY, Huang CJ, Huang LH, Chen IJ, Chiu JP, Hsu CH.
Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial.
PLoS One. Lu PH, Hsu CH. Does supplementation with green tea extract improve acne in post-adolescent women? Complement Ther Med. Mielgo-Ayuso J, Barrenechea L, Alcorta P, Larrarte E, Margareto J, Labayen I. Effects of dietary supplementation with epigallocatechingallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial.
Mirzaei K, Hossein-Nezhad A, Karimi M, Hosseinzadeh-Attar MJ, Jafari N, Najmafshar A, Larijani B. Effect of green tea extract on bone turnover markers in type 2 diabetic patients; a double-blind, placebo-controlled clinical trial study.
Google Scholar. Miyazaki R, Kotani K, Ayabe M, Tsuzaki K, Shimada J, Sakane N, Takase H, Ichikawa H, Yonei Y, Ishii K. Minor effects of green tea catechin supplementation on cardiovascular risk markers in active older people: a randomized controlled trial.
Geriatr Gerontol Int. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans.
Obesity Silver Spring. Nagao T, Meguro S, Hase T, Otsuka K, Komikado M, Tokimitsu I, Yamamoto T, Yamamoto K. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Ryu OH, Lee J, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM.
Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Sone T, Kuriyama S, Nakaya N, Hozawa A, Shimazu T, Nomura K, Rikimaru S, Tsuji I. Randomized controlled trial for an effect of catechin-enriched green tea consumption on adiponectin and cardiovascular disease risk factors.
Suliburska J, Bogdanski P, Szulinska M, Stepien M, Pupek-Musialik D, Jablecka A. Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients.
Biol Trace Elem Res. Tadayon M, Movahedi S, Abedi P, Syahpoosh A. Impact of green tea extract on serum lipid of postmenopausal women: a randomized controlled trial. J Tradit Complement Med. Wu AH, Spicer D, Stanczyk FZ, Tseng CC, Yang CS, Pike MC. Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women.
Cancer Prev Res Phila. Zheng XX, Xu YL, Li SH, Hui R, Wu YJ, Huang XH.
Tea has been cultivated for centuries, beginning diagetes India aand China. Today, Green tea and diabetes is the most widely-consumed Green tea and diabetes in the world, second only to water. Hundreds Balanced diet millions viabetes people drink tea, and studies suggest that green tea Camellia sinesis in particular has many health benefits. There are 3 main varieties of tea, green, black, and oolong. The difference is in how the teas are processed. Green tea is made from unfermented leaves and reportedly contains the highest concentration of powerful antioxidants called polyphenols. You can Green tea and diabetes your city from here. We serve personalized Fat burners for men based on dianetes selected Green tea and diabetes. COVID: Study says this duabetes can find new variants a week more quickly than traditional methods. Refrain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks, name calling or inciting hatred against any community. Help us delete comments that do not follow these guidelines by marking them offensive. Let's work together to keep the conversation civil.Green tea and diabetes -
Several studies have been conducted to understand the effect of green tea on people suffering from type 2 diabetes and you will be surprised to know that most of them showed a positive result.
It has been witnessed that green tea, can reduce the risk of developing diabetes and can even help to control the blood sugar level. As per a study carried on the Japanese population, people who drank six or more cups of green tea in a day were 33 per cent more likely to develop type 2 diabetes as compared to others.
But the benefits of drinking green tea is not only limited to this. According to another study, this beverage can keep your blood sugar level in check and prevents the symptoms from aggravating. Regular intake of green tea decreases fasting glucose levels and fasting insulin levels, which are the two basic parameters used to measure diabetic health.
The benefits of green tea are majorly due to the antioxidant activity of polyphenols and polysaccharides. These two antioxidants are also effective in managing the blood pressure level and lowering the bad cholesterol level in the body.
Green tea is healthy and is not known to have any side-effect on patients suffering from diabetes. But you need to be careful about your intake as it does contain a small amount of caffeine.
You can have green tea times a day. For maximum health benefits do not add sugar to your drink. Unsweetened green tea is more healthy. To make it taste better you may add some lemon juice or mint leaves. Do not steep green tea for more than minutes else your drink will taste bitter.
Besides, choose loose green tea leaves over tea bags to gain maximum health benefits. Please Click Here to subscribe other newsletters that may interest you, and you'll always find stories you want to read in your inbox.
A weekly guide to the biggest developments in health, medicine and wellbeing delivered to your inbox. Thank you for subscribing! Your subscription is confirmed for news related to biggest developments in health, medicine and wellbeing.
Back to Top. Select a City Close. Your current city: Mumbai Mumbai search close. Ahmedabad Hyderabad Bengluru Chandigarh Kolkata Mumbai Chennai Pune Delhi NCR. All Bombay Times print stories are available on.
Nashik Times Aurangabad Times Badlapur Times. We serve personalized stories based on the selected city OK. Hello, Edit Profile Logout. The Times of India. Etimes Briefs Movies TV Web Series Lifestyle Trending Medithon Visual Stories Music Events Videos Theatre Photos Gaming.
Morning habits of famous successful people. Why is it important to love yourself in a relationship. THIS is what Gen Z wants in a relationship. Your daily CAREER horoscope: 15th February, Classic spring dresses for this season.
Video of woman wearing rat-cage heels at New York Fashion Week goes viral. Unique baby names inspired by Mahadev. Jennifer Winget: Fitness tips to borrow from the 'Beyhadh' actor. Hairstyles to steal from Samantha Ruth Prabhu.
A thousand year old Mahavir statue has been discovered in Tamil Nadu! Pulwama attack: Why India observes 14th February as Black Day. Only a true animal lover can spot the elephant in the park. Can a daily dose of cinnamon help lower blood sugar? Search ×. See all results matching 'mub'.
Health News 10 signs of cholesterol seen in the legs. Unlock the secrets to a healthy spine with these expert recommended tips. Bubonic plague, which led Black Death in the 14th century, detected in !
Symptom checker: Unusual signs of Vitamin B12 deficiency. How kissing can help in weight loss, improve gut health. Heart-opening yoga poses perfect for Valentine's Day. What is dolphin yoga pose good for? Easy ways to incorporate it into daily routine. Video: Sushmita Sen's simple yoga poses for better health and flexibility.
Optical Illusion: Only the one with hawk eyes can find the hidden apple in the forest. Only a keen observer can spot the goat in under 5 seconds.
Spot the reptile in this beautiful jungle in under 6 seconds. Only those with a high IQ can easily spot 'TRUCK' in this image. In the end, 92 subjects were randomly assigned. Further 7 subjects in the EGCG group and 8 subjects in the placebo group discontinued the intervention.
Consequently, the data reported here came from 77 subjects Fig. Baseline characteristics for both placebo and EGCG groups are shown in Table 2. No significant differences between any of the group means were detected in demographic, disease duration, glycemic, and lipid parameters Table 2.
To monitor compliance, subjects were required to return all packaging and unused capsules. Each subject received capsules and on average 9. To clarify the effect of concomitant medications on blood pressure, sugar and lipid levels, medications taken by the subjects were reviewed Table 3.
More than half of the participants, 21 subjects Moreover, 6 subjects There was no statistically significant difference in any concomitant medication between the two groups. On the other hands, there is no significant changes in other anthropometric data, including waist circumference, hip circumference, and blood pressure after the week course.
Between-group comparison results are listed in Table 5a. There were no statistically significant differences detected for any of the variables assessed after 16 weeks of decaffeinated GTE versus placebo treatment. Regarding serum lipid profiles, fasting TG decreased from However, fasting TG increased from In spite of the 2.
The total cholesterol level decreased slightly from HDL increased significantly from In the between-group analysis, the percentages of increment in HDL were 6. LDL increased from As for blood sugar and insulin resistance, fasting glucose increased from Neither group showed statistical significance in within-group analysis.
With respect to glycohemoglobin, no statistically significant difference existed between the two groups. Interestingly, insulin decreased markedly from This study evaluates insulin resistance by HOMA-IR index. The HOMA-IR in the EGCG group decreased from 5. Among the obesity-related hormone peptides, ghrelin in the placebo group decreased from Ghrelin in the EGCG group also decreased after the week course but did not achieve statistical significance.
Adiponectin increased markedly in both groups but showed no statistically significant difference between groups. There was also no statistically significant difference in leptin level in the two groups.
The hsCRP significantly increased in both groups with difference of 0. Apo AI increased significantly in both groups and the differences were Apo B also increased significantly in both groups and the differences are GLP-1 in EGCG group increased from 1. However, none of the differences between the groups reached statistical significance table 5b.
In the experimental group, one subject in the experimental group experienced symptoms of epigastric dullness and two developed mild constipation, while one subject in the placebo group had abdominal discomfort. All these symptoms were relieved in the first week after treatment. No major adverse effects of either experimental or placebo group were noted.
The present initial results revealed no statistically significant difference between the EGCG and placebo groups in any of the anthropometric, glycemic, lipid or hormone peptide variables assessed. Despite of adequate sample size after calculation, the metabolic responses to EGCG in those patients with type 2 diabetes were various.
Because the small sample size, the difference between the randomized groups was non-significant in our study. But our within-group analysis explored some new findings on GLP-1, insulin resistance, and lipid profile such as triglyceride and HDL, which were less affected by current antidiabetic medications.
The worldwide prevalence of diabetes has continued to increase dramatically instead of the improvement in outcomes for individual patients with diabetes. Lifestyle modification will undoubtedly play a key role in the ultimate solution to the problem of diabetes [17].
The anti-diabetic effect of green tea extracts may raise the potential of green tea to be the lifestyle modification for diabetic prevention. However, green tea catechins alone do not positively alter anthropometric measurements.
A meta-analysis showed that GTE have a positive effect on weight loss and weight maintenance in obese people BMI between 25 and 30 [19] , [20]. To understand the effect of green tea catechins in anthropometrics of diabetic subjects, and to avoid the potential confounding effect caused by caffeine in green tea, this study used decaffeinated GTE.
Although a decreasing trend in body weight and BMI was observed, GTE did not significantly reduce body weight and BMI of diabetic subjects BMI around 26 in our study. This result is similar to other studies for diabetic rats and diabetic population BMI around 30 [21] , [22].
The difference may be due to the degree of obesity or disease nature, and it merits further investigation. To our knowledge, this is the first study on the effect of GTE on GLP Our results showed significant within-group changes in GLP-1 level and HOMA-IR index after 16 weeks of treatment only in the GTE group, despite there being no significant change in fasting glucose and HbA1c.
Previous research reported a significant interaction between circulating GLP-1, serum HDL, and triglyceride concentrations but not waist circumference, fasting glucose, HbA1c, or presence of diabetes [23].
This result is consistent with the within-group findings in the present study. GLP-1 could lower blood sugar with insulin resistance through up-regulating the pancreatic β-cell to enhance insulin secretion and suppressing glucagon secretion with gastric emptying.
Therefore, the incretin therapy has been used in different stages of diabetes in recent years [24] — [26]. Several studies have shown that T2DM patients generally exhibit attenuated GLP-1 secretion [27] — [29].
In our patients, GLP-1 secretion was lower in both groups and enhanced only in GTE group, but whether the levels of GLP-1 secretion were sufficient could not be determined. Thondam et al. reported that metformin increased serum GLP-1 level in T2DM patients [30] , and metformin could also enhance GLP-1 secretion in GLP-1 producing cell line [31].
This study has avoided the confounding effects of chronic antidiabetic treatment, because these treatments did not show any significant difference between GTE and placebo groups. Although several studies demonstrated the glucose-lowering effects of GTE, the fasting glucose and HbA1c did not decrease after GTE supplementation in our study.
This discrepancy might be due to the more obvious patients with diabetes in our study, whose mean disease duration was around 5 years. The glucose-lowering effects of GTE supplementation are better in patients with diabetes history of less than 5 years than those with a history of more than 5 years.
The increased GLP-1, lower insulin, and decreased HOMA-IR were only significant in the population with disease duration of less than 5 years data was not shown.
Future studies with larger numbers of patients will be required to investigate the clinical characteristics of patients with a better GLP-1 response to GTE.
Virtually every lipid and lipoprotein is affected by insulin resistance and diabetes mellitus, but control of hyperglycemia is unlikely to correct existing dyslipidemia.
Although plasma glucose control is important in reducing microvascular complications due to diabetes, lipid management is also essential in these patients to decrease the incidence of cardiovascular events [32]. In this study, EGCG significantly reduced fasting triglyceride and increased HDL in within-group analysis and caused a decreasing trend of fasting triglycerides in between-group analysis.
Adiponectin, apoA1 and apoB increased significantly in both groups in within-group comparison. Whether adiponectin is positively associated with green tea consumption or not remains controversial [33] — [36]. Green tea extracts also could reduced fat deposit and ameliorated in high fat-fed rats via the adiponectin associated pathway [37].
Since adiponectin plays a role in regulating insulin function and is negatively associated with risk factors for cardiovascular disease, the clinical effects of GTE on adiponectin merits further clarification.
ApoAI and apoB are the major apolipoproteins of HDL and LDL, respectively [38]. In vitro study revealed that EGCG decreased apoB secretion [39] , [40] , which is inconsistent with our findings. Increased serum LDL, rather than decreased triglyceride, possibly leads to this discrepancy.
However, the increase in apoAI after EGCG supplementation is compatible with that in HDL. Current guidelines recommend statin therapy and lifestyle modification as primary intervention for reducing cardiovascular risk in patients with T2DM. EGCG may be the logical dietary supplement for combination with a statin in this setting.
Large prospective studies are needed to evaluate the clinical benefits and tolerability of these combinations. Although the literature reported several suspected green tea-related hepatic reactions [41] , the hepatotoxicity is probably due to metabolism or concomitant medications of a particular patient.
As for the limitation of this study, the relatively small sample size and relatively large variance of the metabolic measurements made the outcome non-significant. Besides, the compliance was monitored only by counting the returned packages and unused capsules. Further research on the bioavailability and pharmacokinetics of EGCG in human studies is needed.
In conclusion, the present study showed no statistically significant difference between decaffeinated GTE and placebo in anthropometrics, glycemic and lipid profiles, as well as obesity-related hormone peptides after 16 weeks of treatment.
Daily taking decaffeinated GTE with dose of mg EGCG for 16 weeks is safe and free of severe adverse effects. The metabolic effects on GLP-1 and insulin response of decaffeinated GTE in humans warrant continued investigation. We thank Miao-Mei Chen and all colleagues at Branch of Linsen and Chinese Medicine, Taipei City Hospital, Taiwan, for their help with this study.
Conceived and designed the experiments: CYL CHH. Performed the experiments: CYL CJH CHH. Analyzed the data: CYL CHH. Wrote the paper: CYL. Browse Subject Areas?
Click through the PLOS taxonomy to find articles in your field. Article Authors Metrics Comments Media Coverage Reader Comments Figures.
Abstract The aim of this study is to investigate the effect of green tea extract on patients with type 2 diabetes mellitus and lipid abnormalities on glycemic and lipid profiles, and hormone peptides by a double-blinded, randomized and placebo-controlled clinical trial.
Trial Registration ClinicalTrials. Introduction Both type 2 diabetes mellitus T2DM and dyslipidemia are individually associated with a cluster of risk factors of atherosclerosis.
Subjects and Methods This clinical trial was conducted from April to March at Taipei City Hospital in Taiwan. Download: PPT. Preparation of samples and treatment Decaffeinated GTE was obtained from the Tea Research and Extension Station, Taoyuan County, Taiwan.
Analysis of obesity-related hormone peptides The levels of obesity-related hormone peptides, including leptin, insulin, ghrelin, adiponectin, apolipoprotein apo A1, apolipoprotein B, and glucagon-like peptide 1 GLP-1 7—36 were measured in the morning after 8—9 hours of fasting.
Quality of life To measure the health-related quality of life HRQOL among our subjects, we used the self-administered life-quality questionnaires, world health organization quality of life-BREF WHOQOL-BREF , Taiwan version which was well validated with consistency coefficients ranging from 0.
Assessment The single primary outcome was defined as the change of triglyceride TG level. Statistical analysis The data were analyzed using SPSS software version Results Data were analyzed on a per-protocol basis, with subject exclusion occurring before release of the double-blind procedure.
Adverse Effects In the experimental group, one subject in the experimental group experienced symptoms of epigastric dullness and two developed mild constipation, while one subject in the placebo group had abdominal discomfort.
Discussion The present initial results revealed no statistically significant difference between the EGCG and placebo groups in any of the anthropometric, glycemic, lipid or hormone peptide variables assessed.
Supporting Information. Checklist S1. s DOC. Protocol S1. s DOCX. Acknowledgments We thank Miao-Mei Chen and all colleagues at Branch of Linsen and Chinese Medicine, Taipei City Hospital, Taiwan, for their help with this study.
Author Contributions Conceived and designed the experiments: CYL CHH. References 1. Badulescu O, Badescu C, Ciocoiu M, Badescu M InterleukinBeta and dyslipidemic syndrome as major risk factors for thrombotic complications in type 2 diabetes mellitus.
Mediators Inflamm View Article Google Scholar 2. Kreisberg RA Diabetic dyslipidemia. Am J Cardiol 67U—73U discussion 85UU. View Article Google Scholar 3. Davidson M A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
Am J Cardiol 19L—27L. View Article Google Scholar 4. Khan N, Mukhtar H Tea polyphenols for health promotion. Life Sci — View Article Google Scholar 5. Jing Y, Han G, Hu Y, Bi Y, Li L, et al. J Gen Intern Med — View Article Google Scholar 6. Nutr Metab Lond 9: View Article Google Scholar 7.
Hursel R, Viechtbauer W, Dulloo AG, Tremblay A, Tappy L, et al. Obes Rev e— View Article Google Scholar 8. Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, et al. A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev — View Article Google Scholar 9.
Agin A, Jeandidier N, Gasser F, Grucker D, Sapin R Use of insulin immunoassays in clinical studies involving rapid-acting insulin analogues: Bi-insulin IRMA preliminary assessment. Clin Chem Lab Med — View Article Google Scholar Starr JI, Mako ME, Juhn D, Rubenstein AH Measurement of serum proinsulin-like material: cross-reactivity of porcine and human proinsulin in the insulin radioimmunoassay.
According to aand American Diabetes Association, a little over Grern percent diabtes people in the United States Green tea and diabetes diabwtes. Several studies have pointed to green tea as Green tea and diabetes potentially effective Body shape success stories to a tex eating plan that may help improve insulin sensitivity. How green tea may work to support insulin sensitivity is not completely clear. Older studies suggest catechins within the tea — also responsible for its anticancer and heart health benefits — may be responsible. In response to this process, the pancreas releases insulin to help cells absorb glucose to be used as cellular fuel. When you have diabetes, this process is hindered.Video
Is Green Tea Good For Diabetes?
die Klugen Sachen, sagt)
Ich denke, dass nichts ernst.